Thursday was another disappointing day on the ASX 200 as the benchmark index fell 0.74% lower.
The S&P/ASX 200 Index (INDEXASX: XJO) shed 49.50 points to close at 6,672.90 points yesterday.
Leading the losses were healthcare, mining and banking stocks, with widespread losses across Aussie equities.
Here's a recap of 3 things you may have missed in Thursday's trade.
1. PolyNovo shares slumped 6.09% lower
The Polynovo Ltd (ASX: PNV) share price fell 6.09% to $1.85 per share to lead the ASX 200 losers on Thursday.
I think this could just be a market correction given there was no Polynovo announcements or releases in yesterday's trade.
Polynovo shares climbed higher last week following a strong annual general meeting (AGM) update and this could just be the market bringing the company's share price back into line.
Given the poor performance of the ASX 200 yesterday, negative momentum may also have been a factor in the slump.
2. Westpac shares fell lower… again
The Westpac Banking Corp (ASX: WBC) share price was under pressure again on the ASX 200 on Thursday.
The big factor causing the decline was AUSTRAC commencing civil proceedings against Westpac under anti-money laundering and counter-terrorism laws.
AUSTRAC is alleging the Aussie bank failed to properly monitor its LitePay international money transfer system for customers.
Commonwealth Bank of Australia Ltd (ASX: CBA) was slapped with a $700 million fine in 2018 for breaching the same laws.
3. Arteria announces equity raising and acquisitions
The Atlas Arteria Ltd (ASX: ALX) share price remains suspended following a $1.35 billion equity raising announcement on the ASX 200 on Thursday.
Atlas Arteria has executed agreements to acquire a further 6.14% indirect interest in APRR and ADELAC. This will lift its indirect interest in APRR to 31.14% and in ADELAC to 31.17%.
The $1.35 billion equity raising will reportedly help Atlas Arteria to complete these acquisitions.
